Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

Abstract Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.

Библиографические подробности
Главные авторы: Pedram Fadavi, Amir Mohammad Arefpour, Ramyar Hariri, Maryam Vasheghani, Maryam Garousi, Farzad Taghizadeh‐Hesary
Формат: Статья
Язык:English
Опубликовано: Wiley 2021-10-01
Серии:Clinical Case Reports
Предметы:
aneurysmal bone cyst
denosumab
management
RANK ligand
resistant
Online-ссылка:https://doi.org/10.1002/ccr3.4993

Internet

https://doi.org/10.1002/ccr3.4993

Схожие документы